BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Blue Earth Diagnostics Announces Addition of Axumin® (Fluciclovine F 18) to NCCN Guidelines® for PET Imaging for Suspected Recurrent Prostate Cancer

  NCCN Guidelines aim to improve quality, effectiveness and efficiency of cancer care. .

  February 20, 2018

   · 

  7 min read
• BioCapital

  The Gastroenterology Group, PC, Announces Expansion Into Clinical Research

  The Gastroenterology Group, PC, a gastroenterology practice based in Reston, Va., announces its expansion into clinical research by partnering with Elligo Health Research.

  February 20, 2018

   · 

  2 min read
• Cardiva Medical Brings Total Financing Round to $41 Million; Announces Sponsorship of AMBULATE Trial, First Vascular Closure Trial Targeted at High Growth Electrophysiology Procedures

  Cardiva Medical ®, an innovator in the field of vascular closure, today announced that the company has closed on $11 million in additional financing – bringing total equity and debt financing in the current round to $41 million.

  February 20, 2018

   · 

  3 min read
• Drug Development

  Sofpironium Bromide Demonstrates Promising Potential

  February 20, 2018

   · 

  5 min read
• Cedars-Sinai and Emulate, Inc. Advance Precision Medicine With Organs-on-Chips, Stem Cells

  Scientists at Cedars-Sinai and Emulate, Inc. are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient’s genetic makeup and disease variant—a new approach to precision medicine for improving patient care and health.

  February 20, 2018

   · 

  6 min read
• Business

  Cullinan Oncology and MAB Discovery Announce Collaboration to Develop Novel Antibody-Based Therapeutics

  Cullinan Oncology, LLC and MAB Discovery GmbH (MABD), announced today the initiation of a collaboration to develop novel antibody therapeutics based on MABD’s unique discovery platform.

  February 20, 2018

   · 

  2 min read
• Top Medical Devices Companies in the World

  Infiniti Research has announced the completion of their latest list of the top medical devices companies in the world.

  February 20, 2018

   · 

  3 min read
• Business

  MiMedx Postpones Release of its Fourth Quarter and Fiscal Year 2017 Financial Results

  MiMedx Group, Inc. announced it will postpone the release of its financial results, as well as the filing of its Form 10-K, for the year ended December 31, 2017.

  February 20, 2018

   · 

  3 min read
• Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Authorization

  Baxter International Inc. (NYSE:BAX) today announced a quarterly cash dividend and an expanded authorization for its share repurchase program.

  February 20, 2018

   · 

  2 min read
• Business

  PharmaJet and Genexine collaborate on DNA vaccine development

  PharmaJet®, the maker of innovative, needle-free injection technology, today announced a global license agreement with Genexine.

  February 20, 2018

   · 

  2 min read